Literature DB >> 10990164

Oxidative mechanisms in tobacco smoke-induced emphysema.

J Seagrave1.   

Abstract

Cigarette smoking is well established as the cause of the majority of cases of emphysema. However, the mechanisms by which exposure of the lung to smoke causes the destruction of the lung parenchyma are not known. Oxidation probably contributes to the progression of this disease in several different ways. Oxidants present in the smoke itself or those generated by inflammatory cells in response to the particulate phase of the smoke inactivate proteinase inhibitors, and the increased inflammatory cells produce and release additional proteinases. The expression and activity of metalloproteinases, which have recently been implicated in the pathogenesis of emphysema, are regulated by redox status. Finally, oxidative damage to structural proteins may potentiate their degradation by the increased proteolytic burden.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10990164     DOI: 10.1080/00984100050116799

Source DB:  PubMed          Journal:  J Toxicol Environ Health A        ISSN: 0098-4108


  7 in total

Review 1.  Cigarette smoke inhibits alveolar repair: a mechanism for the development of emphysema.

Authors:  Stephen I Rennard; Shinsaku Togo; Olaf Holz
Journal:  Proc Am Thorac Soc       Date:  2006-11

2.  The Effect of Cigarette Smoke-derived Oxidants on the Inflammatory Response of the Lung.

Authors:  Robert Foronjy; Jeanine D'Armiento
Journal:  Clin Appl Immunol Rev       Date:  2006-01-01

3.  Superoxide dismutase expression attenuates cigarette smoke- or elastase-generated emphysema in mice.

Authors:  Robert F Foronjy; Oleg Mirochnitchenko; Olga Propokenko; Vincent Lemaitre; Yuxia Jia; Masayori Inouye; Yasunori Okada; Jeanine M D'Armiento
Journal:  Am J Respir Crit Care Med       Date:  2005-12-30       Impact factor: 21.405

4.  Lung fibroblast repair functions in patients with chronic obstructive pulmonary disease are altered by multiple mechanisms.

Authors:  Shinsaku Togo; Olaf Holz; Xiangde Liu; Hisatoshi Sugiura; Koichiro Kamio; Xiangqi Wang; Shin Kawasaki; Youngsoo Ahn; Karin Fredriksson; C Magnus Skold; Kai Christian Mueller; Detlef Branscheid; Lutz Welker; Henrik Watz; Helgo Magnussen; Stephen I Rennard
Journal:  Am J Respir Crit Care Med       Date:  2008-05-08       Impact factor: 21.405

Review 5.  More to Explore: Further Definition of Risk Factors for COPD - Differential Gender Difference, Modest Elevation in PM2.5, and e-Cigarette Use.

Authors:  Yixuan Zhang; Lu Wang; Gökhan M Mutlu; Hua Cai
Journal:  Front Physiol       Date:  2021-05-05       Impact factor: 4.566

6.  Treatment with Bixin-Loaded Polymeric Nanoparticles Prevents Cigarette Smoke-Induced Acute Lung Inflammation and Oxidative Stress in Mice.

Authors:  Alexsandro Tavares Figueiredo-Junior; Samuel Santos Valença; Priscilla Vanessa Finotelli; Francisca de Fátima Dos Anjos; Lycia de Brito-Gitirana; Christina Maeda Takiya; Manuella Lanzetti
Journal:  Antioxidants (Basel)       Date:  2022-06-29

7.  Poly-Ingredient Formulation Bresol(®) Ameliorates Experimental Chronic Obstructive Pulmonary Disease (COPD) in Rats.

Authors:  Mohamed Rafiq; Gollapalle Lakshminarayanashastry Viswanatha; Dattatray Anturlikar Suryakanth; Mohammed Azeemuddin; Mahalingaiah Jagadeesh; Krishna Dhanush; Pralhad Sadashiv Patki
Journal:  Sci Pharm       Date:  2013-05-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.